Keros’ elritercept has shown promising efficacy signals in myelofibrosis and myelodysplastic syndromes and could pose a formidable challenge to Bristol Myers Squibb’s Reblozyl.
Takeda Puts Up to $1.3B on the Line for Keros’ Blood Cancer Anemia Drug Read More »
The deal with Tubulis will help Gilead regain its footing in the ADC space following the withdrawal of Trodelvy in bladder cancer and its late-stage fail in NSCLC.
Gilead Plots ADC Comeback with Potential $465M License Agreement Read More »
The collaboration will see COUR and Roche’s Genentech leverage the biotech’s antigen-specific immune tolerance platform to develop and commercialize therapies for an undisclosed autoimmune disease.
Roche Partners With COUR in Autoimmune Deal Potentially Worth More Than $900M Read More »
At Drexel University’s Graduate School of Biomedical Sciences and Professional Studies, graduate students and active professionals can take interdisciplinary, career-oriented programs designed to help launch their careers and take them to the next level.
Making the Grade: Drexel’s Biomedical Sciences Programs Boost Careers at All Stages Read More »
Alongside the layoffs, Alligator will also suspend work on all of its earlier-stage assets and devote its resources to lead candidate mitazalimab, being developed for the frontline treatment of metastatic pancreatic cancer.
Alligator Axes 70% of Staff Amid ‘Capital Constraints,’ Renews Pancreatic Cancer Focus Read More »
Unos científicos han establecido el límite más restrictivo hasta la fecha en la búsqueda de axiones, unas partículas por ahora solo teóricas que podrían ser la clave para resolver dos de los mayores misterios de la física moderna. El t …
Las emisiones efímeras de ondas de radio de larga duración son un fenómeno nuevo para la ciencia. Y enigmático, porque no se ha conseguido aclarar, al menos hasta ahora, qué las genera y cómo. Puede que la situación comience a cambiar ahora, …
Un fenómeno exótico entre dos estrellas, ¿la causa de unas misteriosas señales de radio? Read More »
Limitar el calentamiento global a 1,5 grados centígrados con respecto a poco antes del inicio de la Revolución Industrial es un objetivo ambicioso. Alcanzar ese objetivo no solo requerirá una reducción masiva de las emisiones de gases con efecto invernadero procedentes de …
